Erik Rockswold, director research and quality, Rayus Radiology, explains the administrative burdens radiology groups experience for little return from the Merit-Based Incentive Payment System.
RBMA board member Kit Crancer offers an update on Medicare reform and advocacy in Congress and how medical societies may be able to get more traction in state legislatures.
Radiology Business Management Association Co-executive Directors Linda Wilgus and Jessica Struve share some of the highlights from the first day of the organization's annual meeting.
Jason Poff, MD, director of innovation deployment for artificial intelligence at Radiology Partners, explains the process he uses to evaluate medical imaging AI.
Smaller health systems are increasingly moving into this realm. Tim Kearns, director of marketing and healthcare IT, Konica Minolta Imaging USA, explains the implications.
Nina Kottler, MD, associate CMO for clinical AI at Radiology Partners, explains the movement toward greater regulation of artificial intelligence and the need to test for bias.
Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency.
Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale University’s Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.
Radiologist Jessica Porembka, MD, FSBI, an associate professor with the breast imaging division at University of Texas Southwestern Medical Center, explains what it means when a mammography report says a patient has architectural distortion.
To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.
The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.
